Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,020,651
+$128,290 QoQ
Shares Held
4,056
-1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.44%
of 13F equity value
Holder Rank
#2,518
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clark Wealth Partners holds $2,314,197 across 10 Drug Manufacturers - General names. ABBV ranks #1 (44.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
4,056 | $1,020,651 | |
| 2 | MRK |
Merck & Co., Inc.
|
5,121 | $658,048 | |
| 3 | LLY |
ELI LILLY & Co
|
353 | $423,398 | |
| 4 | JNJ |
Johnson & Johnson
|
444 | $112,762 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
717 | $41,313 | |
| 6 | GSK |
GSK plc
|
456 | $23,903 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
110 | $13,897 | |
| 8 | AMGN |
Amgen Inc
|
31 | $11,225 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,020,651 | 4,056 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $892,361 | 4,103 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $905,734 | 3,964 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $917,824 | 3,964 | Shares | Sole | 2026-02-04 | |
| 2025-06-30 | $711,852 | 3,835 | Shares | Sole | 2026-02-04 | |
| 2025-03-31 | $826,975 | 3,947 | Shares | Sole | 2026-02-04 | |
| 2024-12-31 | $710,622 | 3,999 | Shares | Sole | 2026-02-04 | |
| No filing history on record for this holder in this stock. | ||||||